Candel Therapeutics, Inc. (CADL)
NASDAQ·Healthcare·Biotechnology
$6.21
-1.27%
Mkt Cap $345.33M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+141.5%
Consensus $15.00 vs current $6.21
NASDAQ·Healthcare·Biotechnology
$6.21
-1.27%
Mkt Cap $345.33M
Buy
6
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
+141.5%
Consensus $15.00 vs current $6.21